ErbB- and MUC1-targeted CAR-T cell immunotherapy of oral squamous cell carcinoma
Chimeric antigen receptor T (CAR-T) cell therapy has shown great success in treating B cell malignancies; however, there are many challenges that limit their therapeutic efficacy in solid tumours. Immunotherapy of head and neck squamous cell carcinoma (HNSCC), and, in particular, oral squamous cell...
Saved in:
Main Authors: | Saffron E. Summers, Vehid Salih, Andrew D. Foey |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Dental Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fdmed.2023.1116402/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
erbB 基因表达与乳腺癌发生的相关关系
Published: (1998-01-01) -
尿液中ErbB3蛋白在肾透明细胞癌早期诊断中的意义
by: 莫承强, et al.
Published: (2018-01-01) -
CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma
by: Laura M. Moser, et al.
Published: (2025-02-01) -
Targeted ErbB4 receptor activation prevents D-galactose-induced neuronal senescence via inhibiting ferroptosis pathway
by: Ji-Ji Dao, et al.
Published: (2025-01-01) -
C-erbB-2/neu基因表达水平与结直肠癌预后的关系
Published: (1994-01-01)